BioCryst Pharmaceuticals
BCRX
#4754
Rank
C$2.90 B
Marketcap
C$11.44
Share price
-0.96%
Change (1 day)
-22.80%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): C$0.36 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are C$0.87 Billion. , an increase over its 2024 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 C$0.36 B-407.51%
2024 -C$0.13 Billion-61.56%
2023 -C$0.32 Billion-7.43%
2022 -C$0.34 Billion34.42%
2021 -C$0.26 Billion-0.55%
2020 -C$0.26 Billion67.88%
2019 -C$0.16 Billion7.55%
2018 -C$0.14 Billion53.92%
2017 -C$90.79 Million19.29%
2016 -C$76.11 Million28.19%
2015 -C$59.38 Million-4.8%
2014 -C$62.37 Million50.09%
2013 -C$41.56 Million-23.29%
2012 -C$54.18 Million-26.19%
2011 -C$73.39 Million54.78%
2010 -C$47.42 Million150.1%
2009 -C$18.96 Million-49.43%
2008 -C$37.5 Million14.07%
2007 -C$32.87 Million-49.31%
2006 -C$64.84 Million72.87%
2005 -C$37.51 Million22.08%
2004 -C$30.73 Million75.3%
2003 -C$17.53 Million-25.36%
2002 -C$23.49 Million225.05%
2001 -C$7.23 Million-56.6%
2000 -C$16.65 Million50.63%
1999 -C$11.06 Million38.05%
1998 -C$8.01 Million-52.46%
1997 -C$16.84 Million58.44%
1996 -C$10.63 Million-14.44%
1995 -C$12.43 Million28.57%
1994 -C$9.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.52 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.81 B 3,644.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$0.97 Billion-362.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.11 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.64 B 73.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.22 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$34.18 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA